Baby formula with immune boosters may cut colds and flu in infants

NCT ID NCT06158659

Completed Disease control Sponsor: Heilongjiang Feihe Dairy Co. Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a special infant formula containing lactoferrin and human milk oligosaccharides (HMOs) could improve immunity in newborns. 240 healthy full-term babies were randomly assigned to receive either the test formula, a standard formula, or breast milk for 12 months. Researchers tracked how often the babies caught colds or the flu to see if the test formula made a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: lactoferrin and human milk oligosaccharides (HMOs) added to infant formula
What this could lead to: If it works, this could point toward a way to strengthen babies' immune systems through formula, potentially reducing common infections like colds and flu.
What could go wrong: This is a completed early-stage study with 240 participants, so results may not apply to all babies. The effect on immunity is measured by infection frequency, which can vary widely, and the formula is not a treatment for existing illness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease common cold influenza

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLD FLU

Contacts and locations

Locations

Jinhua Nanyuan Community Health Center

Jinhua, Zhejiang, China
Li Pu Community Hospital

Jinhua, Zhejiang, China
Qiu Bin Community Hospital

Jinhua, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.